Literature DB >> 8110579

Ketorolac as a component of balanced analgesia after thoracotomy.

I Power1, G M Bowler, G C Pugh, W A Chambers.   

Abstract

Ketorolac 10 mg or 30 mg i.m., 6 hourly or placebo was given to 75 patients who had undergone thoracotomy, in a randomized double-blind study. All subjects were given intercostal nerve blocks with bupivacaine and had access to i.v. patient-controlled morphine. I.m. ketorolac improved the success rate of the analgesic regimen, with fewer patients withdrawing from the study because of inadequate pain relief.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110579     DOI: 10.1093/bja/72.2.224

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Use of ketorolac is associated with decreased pneumonia following rib fractures.

Authors:  Yifan Yang; Jason B Young; Carol R Schermer; Garth H Utter
Journal:  Am J Surg       Date:  2013-10-07       Impact factor: 2.565

3.  A randomized control trial to compare thoracic epidural with intercostal block plus intravenous morphine infusion for postoperative analgesia in patients undergoing elective thoracotomy.

Authors:  Santhosh Vilvanathan; Balaji Kuppuswamy; Raj Sahajanandan
Journal:  Ann Card Anaesth       Date:  2020 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.